RESPIRATORY
July 19, 2017
Updated IDSA/ATS Guidelines on Management of Adults With HAP and VAP
Pharmacists are in a key position to recommend de-escalation of antimicrobial therapy based on culture and sensitivity results and to ensure that patients are receiving the appropriate duration of therapy.
July 19, 2017
Two New Medications for Severe Eosinophilic Asthma
Asthma is a common, chronic respiratory disease in which the lung’s airways become inflamed and narrowed.
July 19, 2017
Ethambutol Hydrochloride Compounded Oral Suspension USP (100 mg/mL)
This preparation should be used not as the sole antituberculous drug, but rather in conjunction with one or more others.
July 19, 2017
Smoking-Cessation Services in Community Pharmacies
Tobacco use is the leading preventable cause of death in the United States.
July 19, 2017
Epidemiology of Chronic Lung Diseases
According to the American Lung Association, more than 35 million Americans have a preventable chronic lung disease.
July 19, 2017
The Pharmacist’s Role in the Treatment and Prevention of Acute Mountain Sickness
Untreated, this condition, which is cased by travel to mountainous regions, can progress to high-altitude cerebral or pulmonary edema.
July 19, 2017
Cessation’s Secret Weapon
Armed with the latest treatment modalities, pharmacists are key in reducing smokers’ ranks.
June 16, 2017
Implementing MTM for COPD
MTM can help patients learn how to manage this respiratory condition and decrease complications.
May 24, 2017
Smoking-Cessation Drugs Found Safe for COPD Patients
